{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T16:13:25Z","timestamp":1787328805395,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s11764-020-00865-z","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T20:02:26Z","timestamp":1582142546000},"page":"434-443","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Rates of underuse of statins among cancer survivors versus controls: NHANES 2011\u20132016"],"prefix":"10.1007","volume":"14","author":[{"given":"Su-Min","family":"Jeong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Wook","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,19]]},"reference":[{"key":"865_CR1","unstructured":"American Cancer Society. Cancer treatment & survivorship facts & figures 2019\u20132021. Atlanta: American Cancer Society; 2019. https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/cancer-treatment-and-survivorship-facts-and-figures\/cancer-treatment-and-survivorship-facts-and-figures-2019-2021.pdf. ."},{"issue":"2","key":"865_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/annonc\/mdw604","volume":"28","author":"NG Zaorsky","year":"2017","unstructured":"Zaorsky NG, Churilla TM, Egleston BL, Fisher SG, Ridge JA, Horwitz EM, et al. Causes of death among cancer patients. Ann Oncol. 2017;28(2):400\u20137.","journal-title":"Ann Oncol"},{"issue":"1","key":"865_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/EDE.0000000000000394","volume":"27","author":"PT Bradshaw","year":"2016","unstructured":"Bradshaw PT, Stevens J, Khankari N, Teitelbaum SL, Neugut AI, Gammon MD. Cardiovascular disease mortality among breast cancer survivors. Epidemiology (Cambridge, Mass). 2016;27(1):6\u201313.","journal-title":"Epidemiology (Cambridge, Mass)"},{"issue":"27","key":"865_CR4","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","volume":"24","author":"NL Keating","year":"2006","unstructured":"Keating NL, O'Malley AJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol. 2006;24(27):4448\u201356.","journal-title":"J Clin Oncol"},{"issue":"16","key":"865_CR5","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1182\/blood-2016-09-740332","volume":"129","author":"FA Van Nimwegen","year":"2017","unstructured":"Van Nimwegen FA, Ntentas G, Darby SC, Schaapveld M, Hauptmann M, Lugtenburg PJ, et al. Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines. Blood. 2017;129(16):2257\u201365.","journal-title":"Blood."},{"issue":"1","key":"865_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ejca.2011.09.015","volume":"48","author":"B Zoller","year":"2012","unstructured":"Zoller B, Ji J, Sundquist J, Sundquist K. Risk of coronary heart disease in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer (Oxford, England : 1990). 2012;48(1):121\u20138.","journal-title":"Eur J Cancer (Oxford, England : 1990)"},{"issue":"10","key":"865_CR7","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1161\/CIRCULATIONAHA.116.024811","volume":"135","author":"MM Fidler","year":"2017","unstructured":"Fidler MM, Reulen RC, Henson K, Kelly J, Cutter D, Levitt GA, et al. Population-based long-term cardiac-specific mortality among 34 489 five-year survivors of childhood cancer in Great Britain. Circulation. 2017;135(10):951\u201363.","journal-title":"Circulation."},{"issue":"48","key":"865_CR8","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","volume":"40","author":"KM Sturgeon","year":"2019","unstructured":"Sturgeon KM, Deng L, Bluethmann SM, Zhou S, Trifiletti DM, Jiang C, et al. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart J. 2019;40(48):3889\u201397.","journal-title":"Eur Heart J"},{"issue":"36","key":"865_CR9","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","volume":"37","author":"JL Zamorano","year":"2016","unstructured":"Zamorano JL, Lancellotti P, Rodriguez Mu\u00f1oz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines\u2002The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(36):2768\u2013801.","journal-title":"Eur Heart J"},{"issue":"4","key":"865_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3322\/caac.21234","volume":"64","author":"TA Skolarus","year":"2014","unstructured":"Skolarus TA, Wolf AMD, Erb NL, Brooks DD, Rivers BM, Underwood W, et al. American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin. 2014;64(4):225\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"865_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/qjmed\/hcq165","volume":"104","author":"EJ Mills","year":"2011","unstructured":"Mills EJ, Wu P, Chong G, Ghement I, Singh S, Akl EA, et al. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170\u2009255 patients from 76 randomized trials. QJM-Int J Med. 2011;104(2):109\u201324.","journal-title":"QJM-Int J Med"},{"issue":"24","key":"865_CR12","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","volume":"73","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):3168\u2013209.","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"865_CR13","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/j.jacc.2014.08.041","volume":"64","author":"TM Maddox","year":"2014","unstructured":"Maddox TM, Borden WB, Tang F, Virani SS, Oetgen WJ, Mullen JB, et al. Implications of the 2013 ACC\/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry. J Am Coll Cardiol. 2014;64(21):2183\u201392.","journal-title":"J Am Coll Cardiol"},{"key":"865_CR14","unstructured":"Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National health and nutrition examination survey: plan and operations, 1999-2010. Vital and health statistics Ser 1, Programs and collection procedures 2013(56):1\u201337."},{"issue":"1","key":"865_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejcsup.2014.03.002","volume":"12","author":"BMP Aleman","year":"2014","unstructured":"Aleman BMP, Moser EC, Nuver J, Suter TM, Maraldo MV, Specht L, et al. Cardiovascular disease after cancer therapy. Eur J Cancer Suppl. 2014;12(1):18\u201328.","journal-title":"Eur J Cancer Suppl"},{"issue":"11","key":"865_CR16","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","volume":"133","author":"RJ Koene","year":"2016","unstructured":"Koene RJ, Prizment AE, Blaes A, Konety SH. Shared risk factors in cardiovascular disease and cancer. Circulation. 2016;133(11):1104\u201314.","journal-title":"Circulation."},{"issue":"7","key":"865_CR17","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cjca.2016.02.065","volume":"32","author":"PC Nathan","year":"2016","unstructured":"Nathan PC, Amir E, Abdel-Qadir H. Cardiac outcomes in survivors of pediatric and adult cancers. Can J Cardiol. 2016;32(7):871\u201380.","journal-title":"Can J Cardiol"},{"issue":"5","key":"865_CR18","doi-asserted-by":"publisher","first-page":"e348","DOI":"10.3747\/co.24.3684","volume":"24","author":"W Law","year":"2017","unstructured":"Law W, Johnson C, Rushton M, Dent S. The Framingham risk score underestimates the risk of cardiovascular events in the HER2-positive breast cancer population. Curr Oncol (Toronto, Ont). 2017;24(5):e348\u2013e53.","journal-title":"Curr Oncol (Toronto, Ont)"},{"issue":"10203","key":"865_CR19","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S0140-6736(19)31886-0","volume":"394","author":"AH Blaes","year":"2019","unstructured":"Blaes AH, Shenoy C. Is it time to include cancer in cardiovascular risk prediction tools? Lancet. 2019;394(10203):986\u20138.","journal-title":"Lancet"},{"issue":"4","key":"865_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7861\/clinmedicine.17-4-293","volume":"17","author":"A Kapoor","year":"2017","unstructured":"Kapoor A, Prakash V, Sekhar M, Greenfield DM, Hatton M, Lean ME, et al. Monitoring risk factors of cardiovascular disease in cancer survivors. Clin Med (Lond). 2017;17(4):293\u20137.","journal-title":"Clin Med (Lond)"},{"issue":"23","key":"865_CR21","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1002\/cncr.32410","volume":"125","author":"TK Stump","year":"2019","unstructured":"Stump TK, Robinson JK, Yanez B, Penedo F, Ezeofor A, Kircher S, et al. Physicians\u2019 perspectives on medication adherence and health promotion among cancer survivors. Cancer. 2019;125(23):4319\u201328.","journal-title":"Cancer."},{"issue":"1","key":"865_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10549-013-2424-2","volume":"138","author":"GS Calip","year":"2013","unstructured":"Calip GS, Boudreau DM, Loggers ET. Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment. Breast Cancer Res Treat. 2013;138(1):225\u201333.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"865_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jacl.2013.10.006","volume":"8","author":"MK Ito","year":"2014","unstructured":"Ito MK, Maki KC, Brinton EA, Cohen JD, Jacobson TA. Muscle symptoms in statin users, associations with cytochrome P450, and membrane transporter inhibitor use: a subanalysis of the USAGE study. J Clin Lipidol. 2014;8(1):69\u201376.","journal-title":"J Clin Lipidol"},{"issue":"4","key":"865_CR24","first-page":"1055","volume":"23","author":"M Jakobisiak","year":"2003","unstructured":"Jakobisiak M, Golab J. Potential antitumor effects of statins (review). Int J Oncol. 2003;23(4):1055\u201369.","journal-title":"Int J Oncol"},{"issue":"19","key":"865_CR25","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/jnci\/djr291","volume":"103","author":"TP Ahern","year":"2011","unstructured":"Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, et al. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Natl Cancer Inst. 2011;103(19):1461\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"865_CR26","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/annonc\/mdt077","volume":"24","author":"HS Park","year":"2013","unstructured":"Park HS, Schoenfeld JD, Mailhot RB, Shive M, Hartman RI, Ogembo R, et al. Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis. Ann Oncol. 2013;24(6):1427\u201334.","journal-title":"Ann Oncol"},{"issue":"6","key":"865_CR27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/aje\/kww245","volume":"186","author":"TL Lash","year":"2017","unstructured":"Lash TL, Riis AH, Ostenfeld EB, Erichsen R, Vyberg M, Ahern TP, et al. Associations of statin use with colorectal cancer recurrence and mortality in a Danish cohort. Am J Epidemiol. 2017;186(6):679\u201387.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"865_CR28","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/bcp.13559","volume":"84","author":"L Xia","year":"2018","unstructured":"Xia L, Jing Z. Impact of postdiagnostic statin use on ovarian cancer mortality: a systematic review and meta-analysis of observational studies. Br J Clin Pharmacol. 2018;84(6):1109\u201320.","journal-title":"Br J Clin Pharmacol"},{"issue":"23","key":"865_CR29","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1016\/j.jacc.2012.07.067","volume":"60","author":"S Seicean","year":"2012","unstructured":"Seicean S, Seicean A, Plana JC, Budd GT, Marwick TH. Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: an observational clinical cohort study. J Am Coll Cardiol. 2012;60(23):2384\u201390.","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"865_CR30","doi-asserted-by":"publisher","first-page":"e005996","DOI":"10.1161\/JAHA.117.005996","volume":"8","author":"J Boulet","year":"2019","unstructured":"Boulet J, Pena J, Hulten EA, Neilan TG, Dragomir A, Freeman C, et al. Statin use and risk of vascular events among cancer patients after radiotherapy to the thorax, head, and neck. J Am Heart Assoc. 2019;8(13):e005996.","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"865_CR31","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1634\/theoncologist.2009-0211","volume":"15","author":"RM Merrill","year":"2010","unstructured":"Merrill RM, Hunter BD. Conditional survival among cancer patients in the United States. Oncologist. 2010;15(8):873\u201382.","journal-title":"Oncologist."},{"issue":"2","key":"865_CR32","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/annonc\/mdw604","volume":"28","author":"NG Zaorsky","year":"2016","unstructured":"Zaorsky NG, Churilla TM, Egleston BL, Fisher SG, Ridge JA, Horwitz EM, et al. Causes of death among cancer patients. Ann Oncol. 2016;28(2):400\u20137.","journal-title":"Ann Oncol"},{"issue":"9","key":"865_CR33","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1200\/JCO.2012.43.0272","volume":"31","author":"CF Snyder","year":"2013","unstructured":"Snyder CF, Frick KD, Herbert RJ, Blackford AL, Neville BA, Wolff AC, et al. Quality of care for comorbid conditions during the transition to survivorship: differences between cancer survivors and noncancer controls. J Clin Oncol. 2013;31(9):1140\u20138.","journal-title":"J Clin Oncol"},{"key":"865_CR34","doi-asserted-by":"publisher","first-page":"231","DOI":"10.14694\/EDBK_156039","volume":"36","author":"MT Halpern","year":"2016","unstructured":"Halpern MT, McCabe MS, Burg MA. The cancer survivorship journey: models of care, disparities, barriers, and future directions. Am Soc Clin Oncol Educ Book. 2016;36:231\u20139.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"3","key":"865_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/aje\/153.3.299","volume":"153","author":"MM Desai","year":"2001","unstructured":"Desai MM, Bruce ML, Desai RA, Druss BG. Validity of self-reported cancer history: a comparison of health interview data and cancer registry records. Am J Epidemiol. 2001;153(3):299\u2013306.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"865_CR36","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/oxfordjournals.aje.a009487","volume":"147","author":"MM Bergmann","year":"1998","unstructured":"Bergmann MM, Calle EE, Mervis CA, Miracle-McMahill HL, Thun MJ, Heath CW. Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries. Am J Epidemiol. 1998;147(6):556\u201362.","journal-title":"Am J Epidemiol"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-020-00865-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11764-020-00865-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-020-00865-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T03:27:29Z","timestamp":1613705249000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11764-020-00865-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,19]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["865"],"URL":"https:\/\/doi.org\/10.1007\/s11764-020-00865-z","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,19]]},"assertion":[{"value":"17 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants provided written informed consent, and the NHANES protocol was approved by the Institutional Review Board of the National Center for Health Statistics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}